Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

77.53 +0.48 (+0.63%)
Streaming Delayed Price Updated: 11:00 AM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
21 22 Next >
News headline image
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That Are Set To Fly This Quarter ↗
 
Via Benzinga
News headline image
7 Leading MedTech Stocks for Next-Gen Health Solutions ↗
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. 
Via InvestorPlace
News headline image
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow' ↗
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut. 
Via Benzinga
Topics Economy
News headline image
Top 3 Health Care Stocks That May Explode In Q3 ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Edwards Lifesciences? ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,200 Today ↗
 
Via Benzinga
News headline image
What 22 Analyst Ratings Have To Say About Edwards Lifesciences ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks to Buy at a 52-Week Low in July ↗
At their 52-week lows, these undervalued healthcare stocks present a favorable return supported by healthcare spending tailwinds. 
Via InvestorPlace
News headline image
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio? ↗
Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT (-12.04%), SMCI (-11.68%), WST (-11.37%), DELL (-11.26%), UPS (-10.96%),... 
Via Benzinga
News headline image
Market Whales and Their Recent Bets on Edwards Lifesciences Options ↗
 
Via Benzinga
News headline image
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review ↗
Small caps continued to lead, while the Nasdaq broke below key levels. 
Via Investor's Business Daily
News headline image
These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results ↗
 
Via Benzinga
News headline image
S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone ↗
 
Via Benzinga
Topics Stocks
News headline image
Edwards Lifesciences Stock Tumbles, Highlights Slowdown In TAVR Business ↗
Edwards Lifesciences reported Q2 results, sales increased 7% to $1.632B, TAVR sales grew 5%, company to acquire JenaValve and Endotronix, lowers TAVR guidance. 
Via Benzinga
News headline image
Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast ↗
 
Via Benzinga
News headline image
Stocks Bouncing Back After Data Hints At 'Soft Landing' ↗
Stocks are on the move midday, as Wall Street weighs an upbeat second-quarter gross domestic product (GDP) reading with the recent tech sector selloff. 
Via Talk Markets
News headline image
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
 
Via Benzinga
News headline image
This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
 
Via Benzinga
News headline image
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday? ↗
Wall Street strongly rebounded Thursday after Wednesday’s slump, driven by stronger-than-expected economic growth in the last quarter, countering concerns of a slowdown. 
Via Benzinga
Topics Economy
News headline image
Ford Posts Downbeat Earnings, Joins MaxLinear, STMicroelectronics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials ↗
Viking Therapeutics stock is up on Thursday as VKTX investors react to the company preparing for a Phase 3 trial of its weight loss drug. 
Via InvestorPlace
News headline image
LINE Stock: 7 Things to Know as Lineage Starts Trading Today ↗
Lineage stock is going to start trading later today and we have all of the details investors need to know about LINE shares on Thursday. 
Via InvestorPlace
News headline image
Why Is Edwards Lifesciences (EW) Stock Down 22% Today? ↗
Edwards Lifesciences stock is down on Thursday as EW investors digest the company's latest earnings report and outlook this morning. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
News headline image
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House ↗
Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech... 
Via Benzinga
Topics Government Stocks
News headline image
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024 ↗
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year ↗
The company now expects full-year sales in its TAVR division to climb 5% to 7%. 
Via Investor's Business Daily
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS